Kezar Life Sciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.29

-0.07 (-0.95%)

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 4 44%

Hold 5 56%

Sell 0 0%

Price Target

Analyst Price Target +158.0% upside

Low Target $12.87

Average Target $18.81

High Target $22.25

Current Price $7.29

Current
$7.29

Target
$18.81

$12.87 $18.81 avg $22.25

Scenario Analysis

Bear Case

$12.87

76.5%

Low target

Base Case

$18.81

+158.0%

Avg target

Bull Case

$22.25

+205.2%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$7.55

-3.4% from high

52-Week Low

$3.53

+106.5% from low

Target vs 52W High

$18.81

+149.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%